Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Zhang T, Kutler D, Scognamiglio T, Gudas LJ, Tang X-. Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongue. Discov Oncol. 2023;14(1):24.

Metzler VM, de Brot S, Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, et al. The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. Front Cell Dev Biol. 2023;11:1116424.

Santo EE, Ribel-Madsen R, Stroeken PJ, de Boer VC, Hansen NS, Commandeur M, et al. FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity. Aging Cell. 2023;22(3):e13763.

Sasset L, Chowdhury KH, Manzo OL, Rubinelli L, Konrad C, J Maschek A, et al. Sphingosine-1-phosphate controls endothelial sphingolipid homeostasis via ORMDL. EMBO Rep. 2023;24(1):e54689.

Schreidah CM, Fahmy LM, Lapolla BA, Kwinta BD, Magro CM, Geskin LJ. Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. Am J Dermatopathol. 2023;45(8):572-576.

Bakht MK, Yamada Y, Ku S-, Venkadakrishnan VB, Korsen JA, Kalidindi TM, et al. Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Nat Cancer. 2023;4(5):699-715.

Boyraz B, Gogakos T, Raskin KA, Nielsen GP. Metastatic Uterine Leiomyosarcoma With Rhabdomyosarcomatous Heterologous Differentiation. Int J Gynecol Pathol. 2023;42(2):151-154.

Vidotto T, Imada EL, Faisal F, Murali S, Mendes AA, Kaur H, et al. Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer. JCI Insight. 2023;8(3).

Sigel C, Wei X-, Agaram N, Sigel K, Raza R, Andrade R, et al. Diagnostic features of low- and high-grade mucinous neoplasms in pancreatic cyst FNA cytology. Cancer Cytopathol. 2023;131(5):325-336.

Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, et al. Retraction Notice to: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas. Cancer Cell. 2023;41(6):1198.